BENGALURU: University of Oxford researchers working in vaccine development effort to prevent Covid-19 have started screening healthy volunteers (aged 18-55) for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The trial has been approved by UK regulators and ethical reviewers and interested candidates will have to volunteer for the programme. The vaccine, the university said, is based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still. “The team will enrol healthy volunteers aged between 18 – 55, who, if they pass screening, will be the first humans to test the new vaccine, called ChAdOx1 nCoV-19,” the varsity said in a statement. The trial will provide valuable information on the safety aspects of the vaccine, as well as its ability to generate an immune response against the virus. The trial — collaboration between the University’s Jenner Institute and Oxford Vaccine Group clinical teams — will recruit up to 510 volunteers. They will receive either the ChAdOx1 nCoV-19 vaccine or a control injection for comparison. “Whilst the team will start screening people now to see if they are eligible to take part in the study, participants… Read full this story
- Coronavirus outbreak: Pfizer's COVID-19 vaccine may not be needed, says Harsh Vardhan
- Matt Hancock says Britain is 'working closely' with Pfizer to roll out the firm's breakthrough Covid-19 vaccine as soon as December 1
- When will a Covid-19 vaccine be available in the UK?
- Coronavirus Live Updates: 41,322 New COVID-19 Cases In India, Cases Cross 9.3 Million Mark
- 'I have a tiny sense of pride': Volunteers in Oxford's coronavirus vaccine study hail 'promising' results as scientists reveal the jab was up to 90% effective in clinical trials
- Another Covid vaccine breakthrough as Moderna reveals its jab is 94.5% effective - making it BETTER than Pfizer's (but the UK hasn't bought any...)
- Millions of people could get less effective coronavirus vaccine because high risk groups must get a jab as soon as possible – even if a better one is round the corner, health chief admits
- Pfizer sends full results on breakthrough Covid vaccine to drugs watchdog in US so it can be approved for December roll-out
- How a handful of scientists developed Oxford vaccine at breakneck speed
- 'I'm so thrilled that you've cracked it!': Prince William congratulates Oxford scientists via Zoom as their Covid vaccine is proved to be 90 per cent effective
Covid-19 vaccine: Research on at Oxford lab, clinical trial on humans soon have 391 words, post on timesofindia.indiatimes.com at March 27, 2020. This is cached page on CuBird. If you want remove this page, please contact us.